• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

53BP1的GAR基序被PRMT1精氨酸甲基化,且对53BP1的DNA结合活性是必需的。

The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity.

作者信息

Boisvert François-Michel, Rhie Alexandre, Richard Stéphane, Doherty Aidan J

机构信息

Terry Fox Molecular Oncology, Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research, Department of Oncology, McGill University, Montréal, Québec, Canada.

出版信息

Cell Cycle. 2005 Dec;4(12):1834-41. doi: 10.4161/cc.4.12.2250. Epub 2005 Dec 14.

DOI:10.4161/cc.4.12.2250
PMID:16294045
Abstract

The p53-binding protein 1 (53BP1) is rapidly recruited to sites of DNA double-strand breaks and forms characteristics nuclear foci, demonstrating its role in the early events of detection, signaling and repair of damaged DNA. 53BP1 contains a glycine arginine rich (GAR) motif of unknown function within its kinetochore-binding domain. Herein, we show that the GAR motif of 53BP1 is arginine methylated by protein arginine methyltransferase 1 (PRMT1), the same methyltransferase that methylates MRE11. 53BP1 contains asymmetric dimethylarginines (aDMA) within cells, as detected with methylarginine-specific antibodies. Amino acid substitution of the arginines within the GAR motif of 53BP1 abrogated binding to single and double-stranded DNA, demonstrating that the GAR motif is required for DNA binding activity of 53BP1. Fibroblast cells treated with methylase inhibitors failed to relocalize 53BP1 to sites of DNA damage and formed few gamma-H2AX foci, consistent with our previous data that MRE11 fails to relocalize to DNA damage sites in cells treated with methylase inhibitors. Our findings identify the GAR motif as a region required for 53BP1 DNA binding activity and as the site of methylation by PRMT1.

摘要

p53结合蛋白1(53BP1)能迅速被招募到DNA双链断裂位点并形成特征性核灶,这表明它在受损DNA的检测、信号传导及修复的早期事件中发挥作用。53BP1在其动粒结合结构域内含有一个功能未知的富含甘氨酸精氨酸(GAR)的基序。在此,我们表明53BP1的GAR基序被蛋白精氨酸甲基转移酶1(PRMT1)甲基化,PRMT1也是使MRE11甲基化的同一种甲基转移酶。用甲基精氨酸特异性抗体检测发现,53BP1在细胞内含有不对称二甲基精氨酸(aDMA)。53BP1的GAR基序内精氨酸的氨基酸替换消除了其与单链和双链DNA的结合,这表明GAR基序是53BP1 DNA结合活性所必需的。用甲基化酶抑制剂处理的成纤维细胞未能将53BP1重新定位到DNA损伤位点,且形成的γ-H2AX灶很少,这与我们之前的研究数据一致,即在用甲基化酶抑制剂处理的细胞中,MRE11未能重新定位到DNA损伤位点。我们的研究结果确定GAR基序是53BP1 DNA结合活性所需的区域,也是PRMT1甲基化的位点。

相似文献

1
The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity.53BP1的GAR基序被PRMT1精氨酸甲基化,且对53BP1的DNA结合活性是必需的。
Cell Cycle. 2005 Dec;4(12):1834-41. doi: 10.4161/cc.4.12.2250. Epub 2005 Dec 14.
2
53BP1 oligomerization is independent of its methylation by PRMT1.53BP1的寡聚化不依赖于PRMT1对其进行的甲基化作用。
Cell Cycle. 2005 Dec;4(12):1854-61. doi: 10.4161/cc.4.12.2282. Epub 2005 Dec 28.
3
Methylation of MRE11 regulates its nuclear compartmentalization.MRE11的甲基化调控其细胞核内的定位。
Cell Cycle. 2005 Jul;4(7):981-9. doi: 10.4161/cc.4.7.1830. Epub 2005 Jul 9.
4
A glycine-arginine domain in control of the human MRE11 DNA repair protein.一个控制人类MRE11 DNA修复蛋白的甘氨酸-精氨酸结构域。
Mol Cell Biol. 2008 May;28(9):3058-69. doi: 10.1128/MCB.02025-07. Epub 2008 Feb 19.
5
Multiple Arginine Residues Are Methylated in Mre11 and Required for Survival Following Ionizing Radiation.多个精氨酸残基在Mre11中发生甲基化,并且是电离辐射后存活所必需的。
G3 (Bethesda). 2018 May 31;8(6):2099-2106. doi: 10.1534/g3.118.200298.
6
Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.组蛋白H3的赖氨酸79甲基化将53BP1靶向至DNA双链断裂处。
Nature. 2004 Nov 18;432(7015):406-11. doi: 10.1038/nature03114. Epub 2004 Nov 3.
7
PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage.蛋白质精氨酸甲基转移酶1(PRMT1)在对选择性抑制和DNA损伤作出反应的胞质小体中积累。
Eur J Histochem. 2014 May 2;58(2):2389. doi: 10.4081/ejh.2014.2389.
8
The Tudor tandem of 53BP1: a new structural motif involved in DNA and RG-rich peptide binding.53BP1的Tudor串联结构域:一种参与DNA和富含RG肽结合的新结构基序。
Structure. 2004 Sep;12(9):1551-62. doi: 10.1016/j.str.2004.06.014.
9
53BP1 exchanges slowly at the sites of DNA damage and appears to require RNA for its association with chromatin.53BP1在DNA损伤位点处交换缓慢,并且其与染色质的结合似乎需要RNA。
J Cell Sci. 2005 May 1;118(Pt 9):2043-55. doi: 10.1242/jcs.02336. Epub 2005 Apr 19.
10
Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain.核仁素羧基端GAR结构域的缺失与位点特异性诱变
Chromosoma. 2003 Apr;111(7):461-9. doi: 10.1007/s00412-003-0231-y. Epub 2003 Feb 26.

引用本文的文献

1
The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.PRMT5的表达与结肠癌术后化疗结果相关。
BMC Cancer. 2025 Apr 23;25(1):760. doi: 10.1186/s12885-025-14161-5.
2
Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.靶向PRMT1-cGAS-STING信号通路以提高抗肿瘤治疗效果。
J Cancer Biol. 2024;5(2):44-60. doi: 10.46439/cancerbiology.5.064.
3
Role of PRMT1 and PRMT5 in Breast Cancer.PRMT1 和 PRMT5 在乳腺癌中的作用。
Int J Mol Sci. 2024 Aug 14;25(16):8854. doi: 10.3390/ijms25168854.
4
PRMT1 in human neoplasm: cancer biology and potential therapeutic target.PRMT1 在人类肿瘤中的作用:癌症生物学和潜在的治疗靶点。
Cell Commun Signal. 2024 Feb 8;22(1):102. doi: 10.1186/s12964-024-01506-z.
5
Exploiting the DNA Damage Response for Prostate Cancer Therapy.利用DNA损伤反应进行前列腺癌治疗。
Cancers (Basel). 2023 Dec 23;16(1):83. doi: 10.3390/cancers16010083.
6
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair.SMYD3通过对非同源末端连接修复中LIG4/XRCC4/XLF复合物的表观遗传调控促进子宫内膜癌。
Oncogenesis. 2024 Jan 8;13(1):3. doi: 10.1038/s41389-023-00503-0.
7
PRMT1 and PRMT5: on the road of homologous recombination and non-homologous end joining.蛋白质精氨酸甲基转移酶1和5:在同源重组和非同源末端连接的道路上
Genome Instab Dis. 2023 Aug;4(4):197-209. doi: 10.1007/s42764-022-00095-w. Epub 2022 Dec 7.
8
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.健康与疾病中的蛋白质翻译后修饰:功能、调控机制及治疗意义
MedComm (2020). 2023 May 2;4(3):e261. doi: 10.1002/mco2.261. eCollection 2023 Jun.
9
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review).PRMTs 在表观遗传修饰和肿瘤信号通路调控中的作用研究进展(综述)。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5510. Epub 2023 Apr 7.
10
Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case-Control Study and In Silico Analyses.细胞周期调控基因 TP53 遗传多态性与多囊卵巢综合征的关系:病例对照研究及计算机分析。
Biochem Genet. 2023 Oct;61(5):1827-1849. doi: 10.1007/s10528-023-10349-1. Epub 2023 Mar 1.